These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8693546)

  • 1. Liver dysfunction in allogeneic bone marrow transplantation recipients.
    Azar N; Valla D; Abdel-Samad I; Hoang C; Fretz C; Sutton L; Fournel JJ; Le Charpentier Y; Binet JL; Leblond V
    Transplantation; 1996 Jul; 62(1):56-61. PubMed ID: 8693546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy.
    Ho GT; Parker A; MacKenzie JF; Morris AJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):157-62. PubMed ID: 15075988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation.
    Shulman HM; Sharma P; Amos D; Fenster LF; McDonald GB
    Hepatology; 1988; 8(3):463-70. PubMed ID: 3131226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological changes in the liver after allogeneic bone marrow transplantation.
    Sloane JP; Farthing MJ; Powles RL
    J Clin Pathol; 1980 Apr; 33(4):344-50. PubMed ID: 6995486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.
    Locasciulli A; Alberti A; de Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Reusser P; Ribaud P; Ljungman P
    Bone Marrow Transplant; 1994 Nov; 14(5):833-7. PubMed ID: 7534164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.
    Shulman HM; Gooley T; Dudley MD; Kofler T; Feldman R; Dwyer D; McDonald GB
    Transplantation; 1995 Apr; 59(7):1015-22. PubMed ID: 7709437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease after bone marrow transplantation.
    Farthing MJ; Clark ML; Sloane JP; Powles RL; McElwain TJ
    Gut; 1982 Jun; 23(6):465-74. PubMed ID: 7042484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.
    Locasciulli A; Testa M; Valsecchi MG; Bacigalupo A; Solinas S; Tomas JF; Ljungman P; Alberti A
    Transplantation; 1999 Nov; 68(10):1486-91. PubMed ID: 10589944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
    Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
    Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in thalassemia: modifications of hepatic iron overload and associated lesions after long-term engrafting.
    Muretto P; Del Fiasco S; Angelucci E; De Rosa F; Lucarelli G
    Liver; 1994 Feb; 14(1):14-24. PubMed ID: 8177025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.
    Iqbal M; Creger RJ; Fox RM; Cooper BW; Jacobs G; Stellato TA; Lazarus HM
    Bone Marrow Transplant; 1996 Apr; 17(4):655-62. PubMed ID: 8722371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhepatitis B-associated liver disease in a renal transplant population.
    Boyce NW; Holdsworth SR; Hooke D; Thomson NM; Atkins RC
    Am J Kidney Dis; 1988 Apr; 11(4):307-12. PubMed ID: 3281452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study.
    Kim BK; Chung KW; Sun HS; Suh JG; Min WS; Kang CS; Sim SI; Shin WS; Kim CC
    Bone Marrow Transplant; 2000 Jul; 26(2):193-7. PubMed ID: 10918430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients.
    Picardi M; Muretto P; De Rosa G; Selleri C; De Renzo A; Persico M; Rotoli B
    Haematologica; 2002 Jun; 87(6):652-7. PubMed ID: 12031923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
    Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G
    Blood; 1995 Aug; 86(4):1614-8. PubMed ID: 7632971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.
    McKay PJ; Murphy JA; Cameron S; Burnett AK; Campbell M; Tansey P; Franklin IM
    Bone Marrow Transplant; 1996 Jan; 17(1):63-6. PubMed ID: 8673057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.